INSMED, Inc.

ARIKAYCE

Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

ARIKAYCE

Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

ARYKAYCE

Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

INSMED

Pharmaceutical and biological preparations for clinical medical use, inoculations, and for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflamatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects;Prints; educational publications, namely, training manuals in the field of science and medicine; magazines in the field of science and medicine;Chemical, scientific and medical research; laboratory research in the field of biochemistry, pharmacology and endocrinology;

INSMED

Pharmaceutical and biological preparations for clinical medical use, namely, for use in IGF-I deficiency, growth hormone insensitivity syndrome, growth disorders, severe burns, severe insulin resistance, Type 2 diabetes, Type 1 diabetes, muscular dystrophies, amyotrophic lateral sclerosis, retinopathy of prematurity, osteoporosis, and AIDS adipose redistribution syndrome; inoculations for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflammatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects;Prints; educational publications, namely, training manuals in the field of science and medicine; magazines in the field of science and medicine;Chemical, scientific and medical research; laboratory research in the field of biochemistry, pharmacology and endocrinology;

INSMED

pharmaceutical preparations for the treatment of pulmonary diseases;

INSMED

pharmaceutical preparations for the treatment of infectious diseases;

IPLEX

Prescription pharmaceutical preparations for the treatment of endocrine and metabolic diseases;

RIKACIA

Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

ZARYKACE

Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;